GA31   Click here for help

GtoPdb Ligand ID: 14580

Immunopharmacology Ligand
Compound class: Peptide
Comment: GA31 is a 31‐mer methionine‐sulfoxidized peptide that is designed to block TREM1-mediated pro-inflammatory signalling [5]. It contains an N-terminal domain comprising human TREM‐1 213‐221 (GF9), plus a chain representing human apo A‐I helix 4 (apo A‐I 123‐144). GA31 was designed using a drug discovery platform termed signaling chain homooligomerization (or "SCHOOL"), which produces receptor-specific peptides that disrupt protein-protein interactions and immunomodulatory signalling by target receptors via a ligand independent mechanism [6]. For targeted intracellular delivery to macrophages, GA31 is formulated with a macrophage-specific lipopeptide complex (GA31-LPC).
References
1. FDA. 
31-amino acid TREM-1 inhibitory peptide.
Accessed on 06/07/2026. Modified on 06/07/2026. www.accessdata.fda.gov, www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1124925
2. Liu W, Liu Y, Guo X, Cao C, Weng S, Peng D. (2026)
The TREM Receptor Family in Cardiovascular Diseases: Functions, Mechanisms and Therapeutic Perspectives.
Int Immunopharmacol, 172: 116167. [PMID:41539000]
3. Nguyen AH, Berim IG, Agrawal DK. (2015)
Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells.
Expert Rev Clin Immunol, 11 (7): 849-57. [PMID:25954917]
4. Pelham CJ, Agrawal DK. (2014)
Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases.
Expert Rev Clin Immunol, 10 (2): 243-56. [PMID:24325404]
5. Shen ZT, Sigalov AB. (2017)
Rationally designed ligand-independent peptide inhibitors of TREM-1 ameliorate collagen-induced arthritis.
J Cell Mol Med, 21 (10): 2524-2534. [PMID:28382703]
6. Sigalov AB. (2020)
SCHOOL of nature: ligand-independent immunomodulatory peptides.
Drug Discov Today, 25 (8): 1298-1306. [PMID:32405248]
7. Tammaro A, Derive M, Gibot S, Leemans JC, Florquin S, Dessing MC. (2017)
TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives.
Pharmacol Ther, 177: 81-95. [PMID:28245991]
8. Xu X, Cai L, Dang X, Han J, Kou Y, Rong C, Kou J. (2026)
Inhibition of TREM1 attenuates myocardial ischemia-reperfusion injury-induced cardiomyocyte pyroptosis by suppressing the activation of the NF-κB signaling pathway.
PLoS One, 21 (1): e0340382. [PMID:41511954]